Codeine phosphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4 + paracetamol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + phenylephrine HCl. It is a pharmaceutical association. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + phenylpropanolamine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes clonidine. It belongs to antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes codeine phosfate + phenylephrine HCl + chlorpheniramine maleate. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-norpseudoephedrine HCI. It belongs to anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine + cetirizina. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine HCI. It belongs to decongestant category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine sulphate. It belongs to decongestant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes dextromethorphan HBr. It belongs to antitussive category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes Di hydro ergotoxin mono methane sulfonate. It belongs to hypertension category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.